MedPath

NAARI PTE. LIMITED

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

FDA:9

Drug Approvals

DROSPIRENONE AND ETHINYL ESTRADIOL

Approval Date
Feb 9, 2024
FDA

Norethindrone and ethinyl estradiol

Approval Date
Jan 12, 2024
FDA

desogestrel and ethinyl estradiol

Approval Date
Jan 12, 2024
FDA

Levonorgestrel and Ethinyl Estradiol

Approval Date
Jan 11, 2024
FDA

Norgestimate and ethinyl estradiol

Approval Date
Jan 9, 2024
FDA

Levonorgestrel and Ethinyl Estradiol

Approval Date
Apr 5, 2023
FDA

desogestrel and ethinyl estradiol and ethinyl estradiol

Approval Date
Apr 5, 2023
FDA

Norethindrone and ethinyl estradiol and ferrous fumarate

Approval Date
Feb 15, 2023
FDA

Affodel

Approval Date
Sep 20, 2022
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.